Dihydroergotamine (Dihydergot) in the treatment of orthostatic circulatory disorders: a double-blind comparison with placebo.
D000328:Adult; D001341:Autonomic Nervous System / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004878:Ergotamine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005221:Fatigue / Q000209:etiology; D005260:Female; D006261:Headache / Q000209:etiology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007024:Hypotension, Orthostatic / Q000150:complications / Q000188:drug therapy*; D008297:Male; D001523:Mental Disorders / Q000209:etiology; D008875:Middle Aged; D009325:Nausea / Q000209:etiology; D010919:Placebos; D011187:Posture; D011311:Pressoreceptors / Q000187:drug effects; D011674:Pulse / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000187:drug effects; D013575:Syncope / Q000209:etiology; D014012:Tinnitus / Q000209:etiology; D014717:Vertigo / Q000209:etiology
D010919:Placebos; D004878:Ergotamine